Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Nelfinavir in Liposarcoma

NCT00233948 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00233948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Nelfinavir in Liposarcoma
Lead sponsor
City of Hope Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2006
Completion date
Not reported
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult liposarcoma, recurrent adult soft tissue sarcoma, stage iii adult soft tissue sarcoma, stage iv adult soft tissue sarcoma